Dangerous Medication Cases in Jasper
Jasper Defective Product Attorney
Looking for a lawyer for your medication injury case in Walker County? There are numerous cases where the public is informed on a regular basis of a dangerous drug that is currently circulated, sometimes these drugs and pharmaceutical prescriptions can be helpful; however there are many cases where severe and adverse side effects are resulting from these drugs. If you have been injured, or you have suffered greatly due to the use of a defective or dangerous drug, then it is important to know that you may be entitled to pursue money damages through a personal injury lawsuit.
Suffering from the use of dangerous drugs can include physical pain and suffering, in addition to the financial hardship that you may have incurred due to hospital bills, loss of wages, and other effects. It is important that you take the necessary steps to pursue the results that you need, and that you have the representation that you need on your side. At Warren & Associates, LLC, we have helped numerous individuals that have been injured in this way in the past, and we can put our extensive skill and experience to work for you.
Have you been harmed by a dangerous medication? Let us help you hold the manufacturer responsible. Start today by filling out our online consultation form and get your case reviewed for free!
Types of Dangerous Drugs
Do you or someone you know have type II diabetes? Have you been recently diagnosed with Pancreatic Cancer? If so, this medical alert is for you. If you are taking Januvia, Victoza, Janumet or Byetta, then your recent diagnosis could be linked to one of these dangerous drugs. Speak with one of our Jasper personal injury attorneys today if you believe that your medication was the direct result of pancreatitis or pancreatic cancer. We offer an initial free consultation so call us today at (800) 481-1467.
Januvia and Janumet were both created and sold by Merck. These two drugs combined $2.58 billion in sales in 2009, $3.34 in 2010 and $4.9 billion in 2011. Janumet, similarly to Januvia, was designed to help lower the high glucose levels in type II diabetes patients. This drug is the combination of sitagliptin and metformin which have been known to cause serious allergic reactions in some patients. Even though this is a relatively new medicine, there have still been an alarming number of cases reported where patients develop cancerous tumors as a result of the sitagliptin. Some common cancerous cases involving Janumet include pancreatic cancer, thyroid cancer and pancreatitis.
This drug is made by Novo Nordisk and it is also used to treat patients who have type II diabetes. Victoza was first approved by the FDA in 2010 but when it was tested in mice and rats, they found that it could be linked with the development of thyroid cancer. Later in 2012, a petition was filed by Public Citizen to remove Victoza from the market because it was being linked to cases of thyroid cancer and pancreatic cancer. It wasn't until March 14, 2013 that the DFA issued a drug safety warning regarding Victoza, but Novo Nordisk refused to adjust their warning labels until they did a study of their own. After conducting five different clinical studies using Victoza, they had seven cases of pancreatitis develop in the patients. When doing the same clinical trial using another diabetes drug, only one case of pancreatitis was found.
This drug was released back in 2005 and it is a twice-daily injection for patients who suffer from type II diabetes. In 2012 alone, Byetta generated over $300 million in sales. However, in a 20122 UCLA drug study, they found that Byetta can increase the chances of developing pancreatic cancer by 290% and it can increase chances of thyroid cancer by 473%. Lately, there has been such a high volume of lawsuits being filed by Byetta users that they have to consolidate the cases.
If you are taking Byetta or any of the medications listed above and you have recently been diagnosed with cancer, speak with a lawyer from our firm about your legal options today!